TNFalpha and response of treatment-resistant adult-onset Still's disease to thalidomide.
C
C
Stambe
I P
IP
Wicks
D000328:Adult; D016022:Case-Control Studies; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007963:Leukocytes, Mononuclear / Q000473:pathology; D018950:Lipopolysaccharide Receptors / Q000032:analysis; D010431:Pentoxifylline / Q000008:administration & dosage / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D012074:Remission Induction; D016706:Still's Disease, Adult-Onset / Q000097:blood / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis* / Q000037:antagonists & inhibitors
D007166:Immunosuppressive Agents; D018950:Lipopolysaccharide Receptors; D010726:Phosphodiesterase Inhibitors; D014409:Tumor Necrosis Factor-alpha; D013792:Thalidomide; D010431:Pentoxifylline